ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY

ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY was reported 37 times

ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 4 0.0002
1 RNA Synthetase Inhibitor Antibacterial [EPC] 2 0.0001
2 CD20-directed Cytolytic Antibody [EPC] 26 0.0001
3 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
4 Alkylating Drug [EPC] 3 0.0000
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
6 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
7 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
8 Thiazide Diuretic [EPC] 1 0.0000
9 Kinase Inhibitor [EPC] 2 0.0000
10 Corticosteroid [EPC] 4 0.0000
11 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
12 GLP-1 Receptor Agonist [EPC] 1 0.0000
13 Platelet Aggregation Inhibitor [EPC] 1 0.0000
14 Benzodiazepine [EPC] 1 0.0000